Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors

Parkinsonism and Related Disorders

Volumn 8, Issue 1, 2001, Pages 7-17

  Satoh, J I ^a   Kuroda, Y ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Synuclein; 14 3 3 protein; BDNF; GDNF; Human neurons; IL 1 ; NTera2; Parkinson's disease; Synphilin 1; TNF

Indexed keywords

ALPHA SYNUCLEIN; BETA ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; NEUROTROPHIC FACTOR; RETINOIC ACID; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; CANCER CELL; CHEMOLUMINESCENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NIGRONEOSTRIATAL SYSTEM; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPHA-SYNUCLEIN; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOKINES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; INTERLEUKIN-1; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNUCLEINS; TERATOCARCINOMA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034919135     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00075-4     Document Type: Article

References (37)

1. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
2. Alpha-synuclein in Lewy body disease and Alzheimer's disease
3. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
4. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
5. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
6. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
7. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
8. Mutation in the α-synuclein gene identified in families with Parkinson's disease
9. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
10. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation
11. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders
12. A Drosophila model of Parkinson's disease
13. Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
14. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
15. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
16. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
17. Neurotrophic factors in neurodegenerative disorders
18. FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
19. Neurotrophins and cytokines in Parkinson's disease
20. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogeneous proteins in terminally differentiated neurons
21. Differential gene expression between human neurons and neuronal progenitor cells in culture: an analysis of arrayed cDNA clones in NTera2 human embryonal carcinoma cell line as a model system
22. Constitutive and cytokine-regulated expression of presenilin-1 and presenilin-2 genes in human neural cell lines
23. β-Catenin expression in human neural cell lines following exposure to cytokines and growth factors
24. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture
25. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease
26. Dopaminergic neurons protected from degeneration by GDNF gene therapy
27. Delayed localization of synelfin (synuclein NACP) to presynaptic terminals in cultured rat hippocampal neurons
28. Expression pattern of synucleins (non-Aβ component of Alzheimer's disease amyloid precursor protein/α-synuclein) during murine brain development
29. Synucleins in synaptic plasticity and neurodegenerative disorders
30. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
31. NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation
32. α-Synucle in.binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356
33. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
34. Synphilin-1 is present in Lewy bodies in Parkinson's disease
35. 14-3-3 proteins: Biological function and domain structure
36. The roles of 14-3-3 proteins in signal transduction
37. B. α-Synuclein shares physical and functional homology with 14-3-3 proteins